150 likes | 296 Views
Workshop on Infectious Disease Ontology Influenza Informatics in the BioHealthBase Bioinformatics Resource Center Richard H. Scheuermann, Ph.D. Department of Pathology U.T. Southwestern Medical Center. BioHealthBase BRC.
E N D
Workshop on Infectious Disease Ontology Influenza Informatics in the BioHealthBase Bioinformatics Resource Center Richard H. Scheuermann, Ph.D. Department of Pathology U.T. Southwestern Medical Center
BioHealthBase BRC • Bioinformatics Resource Centers for Biodefense and Emerging/Re-emerging Infectious Diseases program funded by NIAID (www.brc-central.org) • 8 centers funded • BioHealthBase (www.biohealthbase.org) is an integrated resource • Interrelates data from NCBI, UniProt, Pfam, and other sources • Direct summary and visualization of integrated data • Linkouts to source data sites for additional data details • Allows “one-stop shopping” for science researchers • BioHealthBase provides value-added, pre-computed data • Valuable processed data not available elsewhere • Protein structural and functional predictions • Sequence alignment and polymorphism analysis • Predicted immunological epitopes • BioHealthBase provides a forum for displaying collaborative data • Pathways with Reactome; epitopes with Immune Epitope Database • BioHealthBase emphasizes host-pathogen interactions • Pathogen effects on host cellular pathways • Immune response to pathogen infection • Support of research related to vaccine, therapeutic and diagnostic development
BHB Flu - Home Page & Data Summary www.biohealthbase.org
3D Visualization 302 Flu structures 702 Mtb structures
CEIRS • Motivation • lay the groundwork for the development of new and improved control measures • understanding how influenza viruses evolve, adapt and transmit • identifying immunological factors that determine disease outcome • Research Areas • Research Area 1: Animal Influenza Surveillance Conduct prospective international and/or domestic animal influenza surveillance for the rapid detection and characterization of influenza viruses with pandemic potential. • Research Area 2: Pathogenesis and Host Response Research Conduct research to enhance understanding of the molecular, ecological, and/or environmental factors that influence pathogenesis, transmission, and evolution of influenza viruses; and characterize the protective immune response.
IDO scales of granularity • Host-pathogen interactions occurs at a variety of scales • Ecosystem • Organism • Organ • Cell • Molecule Surveillance Pathogenesis
IDO scales & terms • Ecosystem - transmission, geographic location, population density, routes of migration, specimen isolation procedure, specimen isolation source, vector, carrier, reservoir, environment, prevalence • Organisms - latency, reactivation, disease progression, innate immune response, adaptive immune response, cytokine storm, symptoms (consumption, night sweats, fever, weight loss, wasting, immunosuppression), sterile eradication, delayed-type hypersensitivity, vaccine, surrogate markers of protection, viral load, animal model, pathogenesis, route of treatment, protection, resistance, sensitive, tuberculosis, human immunodeficiency syndrome, infective endocarditis • Organ - granuloma, caseous necrosis, inflammation, endocarditis, lung, peripheral blood, cavity, pericavitary tissue, distant lung, immune system, mucosa, gut lumen, lymph node, inductive site, effector site, tissue damage, • Cell - phagocytosis, pathogen sensing, cytotoxicity, T cells, B cells, macrophages, dendritic cells, bacterium, antibiotic drug, antiviral drug, cell autonomous apoptosis, bystander apoptosis, antigen presentation, infected, activated • Molecules - transport/binding proteins, cell wall synthesis, two component systems, chaperones, detoxification (glyoxalase), DNA repair, lipid biosynthesis, fatty acid degradation, cell surface variable proteins, methylglyoxal, advanced glycation end products, reactive oxygen intermediates (ROIs)
Relationship between experiments and biological knowledge Amplified specimens Manipulated variable Primary isolate Variables OBI:biomaterial transformation OBI:data transformation OBI:assay Amplified specimen Analyte levels Responding variable Correlation/ cause-and-effect
Acknowledgments • Northrop Grumman • Ed Klem • Kevin Biersack • Carey Gire • Jason Lucas • Sharmila Vattikuti • Sanjeev Kumar • Paul Shrabstein • Surabhi Sharma • Tammie Ajayi • Aihui Wang • Zuoming Deng • Jianjun Wang • DeWayne Ejikeme • Vecna • James Wolowicz • Chris Larsen • Al Ramsey • Reactome • Marc Gillespie • Peter D-Eustachio • Lincoln Stein • MITRE • Joanne Luciano • Lynette Hirschman • U.T. Southwestern • Burke Squires • Victoria Hunt • Shubhada Godbole • Roger Chang • Jyothi Noronha • Feng Luo • Cathy Spranger • Kevin McIver • LANL • Catherine Macken • Mira Dimitrijevic • Co-investigators • Barbara Mann (UVA) • Adolfo Garcia-Sastre (MSSM) • Hillary Morrison (MBL) • Louis Weiss (Albert Einstein) • Ellen Vitetta (UTSW) • Amar • X. Wei • David Deng • DMID/NIAID • Valentina DiFrancesco